Skip to main content
    T

    Teleflex Incorporated (TFX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $157.15
    +2.05 (+1.32%)

    Market Cap: $6.15B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Teleflex Incorporated (TFX) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Teleflex (TFX) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Teleflex reported EPS of $2.63, above the $1.92 estimate. It beat the EPS estimate in 7 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    98%(39/40)
    Avg Surprise
    +8.18%
    Streak
    3 Q

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$1.96
    Range$1.80 - $2.16
    14 analysts
    Revenue Consensus
    $583.73M
    Range$563.50M - $610.68M
    14 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$2.39
    Range$2.05 - $2.60
    10 analysts
    EPS Revisions
    4
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$2.45-2.6%
    60d ago$2.45-2.6%
    30d ago$2.45-2.6%
    7d ago$2.47-3.4%
    Current$2.39
    Revenue Consensus
    $563.12M
    Range$556.60M - $567.00M
    7 analysts

    Next Report

    TFX has an expected report date of Feb 24, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 1.6% above the $1.93 reported for the quarter ended Dec 31, 2025.

    TFX Earnings Call

    The latest TFX earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, TFX beat 39 and missed 1. Revenue for the quarter ended Sep 30, 2026 was $567.78M, up 0.1% from $566.95M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$2.63$1.92$1.76 - $2.04+36.98%Beat-28.3%110 up, 1 downNov 5, 2026$567.78M
    Jun 30, 2026$1.76$1.28$1.22 - $1.49+37.50%Beat-52.8%130 up, 2 downAug 6, 2026$570.33M
    Mar 31, 2026$1.39$1.21$1.15 - $1.33+14.88%Beat-52.2%91 up, 0 downMay 7, 2026$548.26M
    Dec 31, 2025$1.93$3.73$3.55 - $4.08-48.26%Miss-50.4%100 up, 3 downFeb 26, 2026N/A
    Sep 30, 2025$3.67$3.38$3.34 - $3.58+8.58%Beat+5.2%124 up, 5 downNov 6, 2025$566.95M
    Jun 30, 2025$3.73$3.37$3.24 - $3.42+10.68%Beat+9.1%11N/AJul 31, 2025$442.52M
    Mar 31, 2025$2.91$2.88$2.71 - $3.18+0.89%Beat-9.3%121 up, 2 downMay 1, 2025$414.26M
    Dec 31, 2024$3.89$3.88$3.77 - $3.98+0.26%Beat+15.1%12N/AFeb 27, 2025N/A
    Sep 30, 2024$3.49$3.39$3.32 - $3.48+2.95%Beat-4.1%130 up, 0 downOct 31, 2024$764.38M
    Jun 30, 2024$3.42$3.33$3.30 - $3.37+2.70%Beat+0.3%141 up, 0 downAug 1, 2024$749.69M
    Mar 31, 2024$3.21$3.07$3.04 - $3.13+4.56%Beat+3.9%140 up, 0 downMay 2, 2024$737.85M
    Dec 31, 2023$3.38$3.26$3.20 - $3.36+3.68%Beat-4.0%140 up, 0 downFeb 22, 2024N/A
    Sep 30, 2023$3.64$3.27$3.18 - $3.33+11.31%Beat+11.3%141 up, 3 downNov 2, 2023$746.39M
    Jun 30, 2023$3.41$3.21$3.11 - $3.34+6.23%Beat+0.6%151 up, 0 downAug 3, 2023$743.26M
    Mar 31, 2023$3.09$2.98$2.80 - $3.11+3.69%Beat+7.3%140 up, 0 downMay 4, 2023$710.93M
    Dec 31, 2022$3.52$3.44$3.36 - $3.51+2.33%Beat-2.2%140 up, 0 downFeb 23, 2023$758.00M
    Sep 30, 2022$3.27$3.11$3.00 - $3.26+5.14%Beat-6.8%140 up, 0 downOct 27, 2022$686.79M
    Jun 30, 2022$3.39$3.34$3.28 - $3.40+1.50%Beat+1.2%120 up, 0 downJul 28, 2022$704.54M
    Mar 31, 2022$2.88$2.72$2.69 - $2.96+5.88%Beat+0.3%101 up, 0 downApr 28, 2022$641.72M
    Dec 31, 2021$3.60$3.53$3.49 - $3.59+1.98%Beat+10.8%101 up, 0 downFeb 24, 2022$761.91M
    Sep 30, 2021$3.51$3.03$2.95 - $3.11+15.84%Beat+26.7%110 up, 0 downOct 28, 2021$700.25M
    Jun 30, 2021$3.35$2.87$2.66 - $2.93+16.72%Beat+73.6%10N/AJul 29, 2021$713.47M
    Mar 31, 2021$2.87$2.42$2.37 - $2.67+18.59%Beat+5.5%11N/AApr 29, 2021$633.92M
    Dec 31, 2020$3.25$3.05$2.99 - $3.09+6.56%Beat-0.9%11N/AFeb 25, 2021$711.18M
    Sep 30, 2020$2.77$2.24$2.03 - $2.43+23.66%Beat-6.7%11N/AOct 29, 2020$628.30M
    Jun 30, 2020$1.93$1.25$1.01 - $1.77+54.40%Beat-27.4%13N/AJul 30, 2020$567.03M
    Mar 31, 2020$2.72$2.24$1.93 - $2.50+21.43%Beat+21.4%12N/AApr 30, 2020$630.64M
    Dec 31, 2019$3.28$3.22$3.18 - $3.27+1.86%Beat+18.4%13N/AFeb 20, 2020$680.95M
    Sep 30, 2019$2.97$2.75$2.72 - $2.83+8.00%Beat+17.9%13N/AOct 31, 2019$648.32M
    Jun 30, 2019$2.66$2.59$2.54 - $2.66+2.70%Beat+7.7%13N/AAug 1, 2019$652.51M
    Mar 31, 2019$2.24$2.17$2.15 - $2.22+3.23%Beat+4.2%12N/AMay 2, 2019$613.58M
    Dec 31, 2018$2.77$2.76$2.71 - $2.83+0.36%Beat+13.5%13N/AFeb 21, 2019$641.62M
    Sep 30, 2018$2.52$2.42$2.36 - $2.46+4.13%Beat+18.9%12N/ANov 1, 2018$609.67M
    Jun 30, 2018$2.47$2.41$2.36 - $2.45+2.49%Beat+21.1%11N/AAug 2, 2018$609.87M
    Mar 31, 2018$2.15$1.94$1.92 - $1.97+10.82%Beat+19.4%11N/AMay 3, 2018$587.23M
    Dec 31, 2017$2.44$2.40$2.37 - $2.46+1.67%Beat+14.6%12N/AFeb 22, 2018$595.11M
    Sep 30, 2017$2.12$2.00$1.95 - $2.08+6.00%Beat+17.8%11N/ANov 2, 2017$534.70M
    Jun 30, 2017$2.04$1.91$1.89 - $1.93+6.81%Beat+7.9%11N/AAug 3, 2017$528.61M
    Mar 31, 2017$1.80$1.69N/A+6.51%Beat+18.4%N/AN/AMay 4, 2017$487.88M
    Dec 31, 2016$2.13$2.09N/A+1.91%Beat+6.0%N/AN/AFeb 23, 2017$513.93M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $12.24, down 12.6% from the year before. It was $7.34 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$12.24-12.6%
    Dec 31, 2024$14.01+3.6%
    Dec 31, 2023$13.52+3.5%
    Dec 31, 2022$13.06-2.0%
    Dec 31, 2021$13.33+24.9%
    Dec 31, 2020$10.67-4.3%
    Dec 31, 2019$11.15+12.5%
    Dec 31, 2018$9.91+18.0%
    Dec 31, 2017$8.40+14.4%
    Dec 31, 2016$7.34N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,200 words across 14 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,23414
    2026Q2Jun 30, 20268,23415
    2026Q1Mar 31, 20266,68314
    2025Q4Dec 31, 20255,65813
    2025Q3Sep 30, 20255,63111
    2025Q2Jun 30, 20257,02312
    2025Q1Mar 31, 20258,07715
    2024Q4Dec 31, 20248,84815

    2026Q3 Earnings Call

    Opening remarks

    Lawrence Keusch Vice President of Investor Relations and Strategy Development Good morning, everyone, and welcome to the Teleflex Incorporated Third Quarter 2026 Earnings Conference Call. The press release and slides to accompany this call are available on our website at teleflex.com. As a reminder, a replay will be available on our website. Those wishing to access the replay can refer to our press release from this morning for details. Joining me on today's call are Jason Weidman, President and Chief Executive Officer, and John Deren, Executive Vice President and Chief Financial Officer. Jason and John will provide prepared remarks, and then we will open the call to Q&A. Before we begin, I'd like to remind you that some of the matters discussed in the conference call will contain forward-looking statements regarding future events as outlined in the slides posted to the Investor Relations section of the Teleflex website. We wish to caution you that such statements are, in fact, forward-looking in nature and are subject to risks and uncertainties, and actual events or results may differ materially. The factors that could cause actual results or events to differ materially include, but are not limited to, factors referenced in our press release today as well as our filings with the SEC, including our Form 10-K, which can be accessed on our website. Now I'll turn the call over to Jason for his remarks.

    Jason Weidman President and Chief Executive Officer Thank you, Larry, and good morning, everyone. Let me start this morning with the highlights of the quarter. Teleflex delivered strong third quarter performance with pro forma adjusted constant currency revenue growth of 3% and adjusted operating margin of 25%. Even excluding the benefit of the refund for IEEPA tariffs paid in 2026, adjusted margins saw modest expansion and earnings per share grew. Vascular and Surgical continued to deliver solid growth, while Interventional returned to positive growth, improving on its second quarter performance. We also continued our return of capital to shareholders with $350 million in additional share buybacks, $100 million more than previously announced between the beginning of Q3 and today. As John will discuss, we are increasing our full year adjusted EPS guidance to reflect our third quarter progress and our outlook for the remainder of the year. I've now been in the CEO role here at Teleflex for about 5 months. I've continued my extensive review of the organization, spent significant time visiting sites and customers across the globe, and ensured focus on our critical executional priorities. On our last call, I said I would have more to say about my perspective on the business and our future direction by this call.

    Frequently Asked Questions About TFX

    When is Teleflex's next earnings date?

    Teleflex's next earnings report is expected for Feb 24, 2027.

    Did TFX beat earnings estimates last quarter?

    Yes. Teleflex reported EPS of $2.63 for the quarter ended Sep 30, 2026, above the $1.92 estimate, a 36.98% surprise.

    What EPS do analysts expect from TFX next quarter?

    The consensus EPS estimate for Teleflex for the quarter ending Dec 31, 2026 is $1.96 from 14 analysts, with estimates from $1.80 to $2.16.

    How often does TFX beat earnings estimates?

    Teleflex beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +7.69%.